Wellthy Therapeutics to Join FH21!


Frontiers Health is very happy to announce the addition of Wellthy Therapeutics as a FH21 partner.

As a leading digital therapeutics company, its proprietary Wellthy CARE ™ DTx platform has a proven track record of enabling the development and commercialization of digital patient support programs, digital therapeutics, and regulatory compliant companion SaMD (Software as a Medical Device) solutions. In addition to improving patient lives in the areas of cardiology, women’s health, diabetes, pulmonology, and select rare diseases, Wellthy CARE™ enables biopharma and medtech organizations throughout Europe and Asia to not only deploy and scale digital health solutions but also accelerate time to market while minimizing risk and cost.

For more about Wellthy Therapeutics and other conference sponsors, be sure to keep an eye out for conference updates here as well as on LinkedIn and Twitter.

Get your pass and stay up-to-date about the 2021 Global Hybrid Conference

MORE STORIES

IF YOU WOULD LIKE TO TAKE PART IN THE EVENT,
OR BE THE FIRST TO FIND OUT ABOUT OUR 2021 EDITION


MORE POSTS